News for iBio, Inc. (IBIO)

SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody therapies, today announced that iBio's common stock has been approved for listing on the Nasdaq Capital

We recently published a list of 10 Stocks Insiders Are Buying This Year. In this article, we are going to take a look at where Ibio, Inc.

On December 31, 2024, ADAR1 Capital Management, LLC (Trades, Portfolio) executed a notable transaction involving iBio Inc. The firm increased its stake in the b

Opaleye Management Inc. (Trades, Portfolio) recently executed a significant stock transaction, acquiring an additional 375,000 shares of iBio Inc. on December 3

**media[537048]**

Insider Trading Roundup: Monday's Top Buys and Sells in US Stocks

**media[507928]**

On December 31, 2024, SABBY MANAGEMENT, LLC (Trades, Portfolio) executed a strategic acquisition of 19,250 shares in iBio Inc, a biotechnology company, at a pri

**media[504088]**

iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects AAR Co...

SAN DIEGO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody immunotherapies, today announced its...

Life sciences industry veteran to lead strategic alliances for iBio’s machine learning platform for antibody discovery and pipeline of cardiometabolic...

Obesity is a multifactorial disorder, which is often associated with many other significant diseases such as diabetes, hypertension and other...

iBio Inc. revises executive compensation and ethics code

The past few years have been a topsy-turvy ride for the biotech sector.

MBIA Inc. (MBI) is up over 57% at in Friday's pre-market trading. The following are some of the other stocks making big moves..

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted better-than-expected results for its third quarter and issued a stro